<VariationArchive VariationID="502014" VariationName="NM_000341.4(SLC3A1):c.163del (p.Gln55fs)" VariationType="Deletion" Accession="VCV000502014" Version="12" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2018-04-02" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="493438" VariationID="502014">
      <GeneList>
        <Gene Symbol="SLC3A1" FullName="solute carrier family 3 member 1" GeneID="6519" HGNC_ID="HGNC:11025" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="44275480" stop="44322437" display_start="44275480" display_stop="44322437" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="44502596" stop="44547962" display_start="44502596" display_stop="44547962" Strand="+" />
          </Location>
          <OMIM>104614</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000341.4(SLC3A1):c.163del (p.Gln55fs)</Name>
      <CanonicalSPDI>NC_000002.12:44275695:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="44275696" stop="44275696" display_start="44275696" display_stop="44275696" variantLength="1" positionVCF="44275695" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="44502835" stop="44502835" display_start="44502835" display_stop="44502835" variantLength="1" positionVCF="44502834" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Q55fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.44502837del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.44502837del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.44275698del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.44275698del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008233.1" sequenceAccession="NG_008233" sequenceVersion="1" change="g.5241del">
            <Expression>NG_008233.1:g.5241del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000341.4" sequenceAccession="NM_000341" sequenceVersion="4" change="c.163del" MANESelect="true">
            <Expression>NM_000341.4:c.163del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000332.2" sequenceAccession="NP_000332" sequenceVersion="2" change="p.Gln55fs">
            <Expression>NP_000332.2:p.Gln55fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA1640035" DB="ClinGen" />
        <XRef Type="rs" ID="779932118" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000341.4(SLC3A1):c.163del (p.Gln55fs) AND not provided" Accession="RCV000597459" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-17" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000341.4(SLC3A1):c.163del (p.Gln55fs) AND Cystinuria" Accession="RCV001234999" Version="7">
        <ClassifiedConditionList TraitSetID="1615">
          <ClassifiedCondition DB="MedGen" ID="C0010691">Cystinuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-04-02" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11260385</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24610330</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25109415</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25964309</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SLC3A1</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1615" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1217" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cystinuria</ElementValue>
                <XRef ID="22232" DB="GeneTests" />
                <XRef ID="Cystinuria/2081" DB="Genetic Alliance" />
                <XRef ID="HP:0003131" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0009067" DB="MONDO" />
                <XRef ID="85020001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYSTINURIA, TYPE I</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYSTINURIA, TYPE II</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYSTINURIA, TYPE III</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinuria, non-type I</ElementValue>
                <XRef ID="UWMG_9204648" DB="CSER _CC_NCGL, University of Washington" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CSNU1</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CSNU3</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CSNU</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystinuria is an autosomal disorder characterized by impaired epithelial cell transport of cystine and dibasic amino acids (lysine, ornithine, and arginine) in the proximal renal tubule and gastrointestinal tract. The impaired renal reabsorption of cystine and its low solubility causes the formation of calculi in the urinary tract, resulting in obstructive uropathy, pyelonephritis, and, rarely, renal failure (summary by Barbosa et al., 2012).</Attribute>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6237" />
                <XRef ID="6237" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21863055</ID>
              </Citation>
              <XRef ID="214" DB="Orphanet" />
              <XRef ID="C0010691" DB="MedGen" />
              <XRef ID="MONDO:0009067" DB="MONDO" />
              <XRef Type="MIM" ID="220100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003131" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1381001" SubmissionDate="2018-09-19" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="62151_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000708604" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC3A1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="-" referenceAllele="C" start="44502837" stop="44502837" variantLength="1" />
            <GeneLocation>NM_000341.3:Ex1</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD982949" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SLC3A1</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2742693" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="2476229|MedGen:C0010691" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001407663" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24610330</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25109415</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25964309</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11260385</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25964309</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gln55Argfs*51) in the SLC3A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC3A1 are known to be pathogenic (PMID: 24610330, 25109415, 25964309). This variant is present in population databases (rs779932118, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with cystinuria (PMID: 11260385, 25964309). This variant is also known as c.161delC. ClinVar contains an entry for this variant (Variation ID: 502014). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC3A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.44502835del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010691" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3055302" SubmissionDate="2021-03-31" DateLastUpdated="2021-04-13" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="chr2:44502833-44502835:1e8b763a44076fb61edb1f0115e0844f" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001554071" DateUpdated="2021-04-13" DateCreated="2021-04-13" Type="SCV" Version="1" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SLC3A1 p.Q55Rfs*51 variant was identified in 13 of 634 proband chromosomes (frequency: 0.021) from individuals or families with cystinuria; the variant has been reported in cystinuria patients in the heterozygous, compound heterozygous and homozygous state (Bisceglia_2001_PMID:11260385; Gitomer_1998_PMID:9768685; Font-Llitjâˆšâ‰¥s_2005_PMID:15635077; Tostivint_2017_PMID:28646536; Brauers_2006_PMID:18947684). The variant was identified in dbSNP (ID: rs779932118) and ClinVar (classified as pathogenic by EGL Genetic Diagnostics). The variant was identified in control databases in 17 of 282536 chromosomes at a frequency of 0.00006017 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 16 of 128970 chromosomes (freq: 0.000124) and Latino in 1 of 35410 chromosomes (freq: 0.000028), but was not observed in the African, Ashkenazi Jewish, East Asian, European (Finnish), Other, or South Asian populations. The c.161del variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 55 and leads to a premature stop codon 51 amino acids downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the SLC3A1 gene are an established mechanism of disease in cystinuria and is the type of variant expected to cause the disorder. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC3A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="T" referenceAllele="TC" start="44502834" stop="44502835" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1381001" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3055302" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2742693" TraitType="Disease" MappingType="XRef" MappingValue="C0010691" MappingRef="MedGen">
        <MedGen CUI="C0010691" Name="Cystinuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

